Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MaxCyte ( (MXCT) ) has issued an announcement.
MaxCyte, Inc., a non-UK issuer, has announced a significant change in its voting rights structure due to an acquisition or disposal of voting rights and financial instruments by BlackRock, Inc. The notification indicates that BlackRock’s total voting rights in MaxCyte have increased to 9.12%, up from a previous 8.24%. This change reflects BlackRock’s strategic positioning and influence within MaxCyte, potentially impacting the company’s governance and stakeholder interests.
More about MaxCyte
Learn more about MXCT stock on TipRanks’ Stock Analysis page.